Revise BE study protocol: CDSCO Panel tells Akum Pharma on FDC of Chlorthalidone, Cilnidipine, Bisoprolol film-coated tablet
New Delhi: Citing that individual and innovators’ products should be taken as a reference product in the proposed bioequivalence study protocol, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Akum Pharmaceutical to revise the bioequivalence (BE) study protocol for Chlorthalidone IP 6.25mg plus Cilnidipine […]